Vanda Pharmaceuticals Inc (VNDA)

NASDAQ
9.55
-0.12(-1.19%)
  • Volume:
    174,555
  • Day's Range:
    9.50 - 9.80
  • 52 wk Range:
    9.24 - 21.44

VNDA Overview

Prev. Close
9.67
Day's Range
9.5-9.8
Revenue
266.2M
Open
9.6
52 wk Range
9.24-21.44
EPS
0.196
Volume
174,555
Market Cap
539.6M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
415,394
P/E Ratio
56.72
Beta
0.463
1-Year Change
-43.97%
Shares Outstanding
56,561,462
Next Earnings Date
Nov 09, 2022
What is your sentiment on Vanda?
or
Vote to see community's results!

Vanda Pharmaceuticals Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Vanda Pharmaceuticals Inc Analysis

Vanda Pharmaceuticals Inc Company Profile

Vanda Pharmaceuticals Inc Company Profile

Employees
278

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to address unmet medical needs. Its commercial portfolio consists of two products, HETLIOZ (tasimelteon) for the treatment of jet lag disorder, pediatric non-24, delayed sleep phase disorder (DSPD) and autism spectrum disorder (ASD), and Fanapt (iloperidone) for the treatment of bipolar disorder and Parkinson's disease psychosis (PDP) and a long acting injectable (LAI) formulation for the treatment of schizophrenia. Its other product pipeline includes Tradipitant (VLY-686), VTR-297, VSJ-110 and BPO-27. VLY-686, is for the treatment of gastroparesis, motion sickness, atopic dermatitis and COVID-19 pneumonia. VTR-297, is for the treatment of hematologic malignancies. VSJ-110, is for the treatment of dry eye and ocular inflammation. BPO-27, is for the treatment of secretory diarrhea disorders, including cholera. Its other product includes VQW-765.

Read More

Analyst Price Target

Average10.00 (+4.82% Upside)
High10
Low10
Price9.54
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • 🚀🚀🚀
    1
    • Why down??
      1